These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1226479)

  • 1. Controlled specific immunotherapy of the nasal atopy.
    Crifó S
    Rhinology; 1975 Dec; 13(4):179-83. PubMed ID: 1226479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some immunological parameters in serum and nasal secretion in subjects with vasomotor and allergic rhinitis and nasal polyps - a comparative study.
    Pulido V; García-Calderón PA
    Rhinology; 1983 Mar; 21(1):29-37. PubMed ID: 6857102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific local immunotherapy in the treatment of hay fever.
    Filiaci F; Di Filippo S; Lucarelli N; Zambetti G
    Rhinology; 1984 Dec; 22(4):261-8. PubMed ID: 6522976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release.
    Platts-Mills TA; von Maur RK; Ishizaka K; Norman PS; Lichtenstein LM
    J Clin Invest; 1976 Apr; 57(4):1041-50. PubMed ID: 59737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with alginate-conjugated two grass pollen extract in patients with allergic rhinoconjunctivitis.
    Tari MG; Mancino M; Pozzuoli G; Mauro B; Verga A; Monti G
    Allergol Immunopathol (Madr); 1990; 18(1):35-40. PubMed ID: 2382596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protein immunoelectrophoresis of the nasal secretion in rhinitis of allergic origin].
    Rozprimová L; Steffl M
    Cesk Otolaryngol; 1971 Jun; 20(3):103-7. PubMed ID: 5564729
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of specific IgE and IgG serum antibodies during immunotherapy in hay fever patients by RAST.
    Osterhage F; Wippler M; Kalden JR; Deicher H
    Z Immunitatsforsch Immunobiol; 1977 Sep; 153(3):189-203. PubMed ID: 930233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic problems before specific immunotherapy in patients with late-summer seasonal allergic rhinitis].
    Kadocsa E
    Orv Hetil; 1994 Sep; 135(36):1963-6. PubMed ID: 7936601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of therapeutic success of a specific immunotherapy of grass pollen allergy].
    Horak F; Jäger S; Türk R
    Laryngol Rhinol Otol (Stuttg); 1983 Sep; 62(9):416-8. PubMed ID: 6355717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoglobulins A, M, G and E in the serum and nasal discharge in hay fever].
    Obtułowicz K; Wróblewska I; Radwan J; Miecznik B
    Pol Tyg Lek; 1985 Mar 25-31; 40(12-13):369-72. PubMed ID: 4011484
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoglobulin E distribution in atopic nasal mucosa.
    Testa B; Cuccurullo L; Mesolella C; Ferraraccio F
    Laryngoscope; 1992 Mar; 102(3):327-9. PubMed ID: 1545659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response.
    Rondón C; Doña I; López S; Campo P; Romero JJ; Torres MJ; Mayorga C; Blanca M
    Allergy; 2008 Oct; 63(10):1352-8. PubMed ID: 18782115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rationale for immunotherapy in respiratory allergies.
    Norman PS
    Trans Am Clin Climatol Assoc; 1978; 89():119-29. PubMed ID: 309208
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring of different forms of immunotherapy by measuring of grass pollen specific "blocking antibodies".
    Maasch HJ; Puttonen E
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):91-100. PubMed ID: 6625591
    [No Abstract]   [Full Text] [Related]  

  • 17. Rush immunotherapy with a standardized Bermuda grass pollen extract.
    Armentia-Medina A; Blanco-Quiros A; Martin-Santos JM; Alvarez-Cuesta E; Moneo-Goiri I; Carreira P; Losada-Cosmes E
    Ann Allergy; 1989 Aug; 63(2):127-35. PubMed ID: 2669567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the levels of artemisia pollen specific antibodies during rush immunotherapy for pollinosis].
    Wang Y; Wang X; Zheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Aug; 32(4):216-7. PubMed ID: 10743168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of quantifying skin reactivity in treating allergic rhinitis with immunotherapy.
    Trevino RJ; Veling MC
    Ear Nose Throat J; 2000 May; 79(5):362-4, 366. PubMed ID: 10832201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.